Withania somnifera (ashwagandha, "winter cherry," "Indian ginseng") is a small shrub native to India, North Africa, and the Mediterranean that has been used in Ayurvedic medicine for over 3,000 years as a "rasayana" — a rejuvenating tonic. Unlike most herbs with ancient use and weak modern evidence, ashwagandha has accumulated a genuinely impressive body of controlled human trial data over the past 15 years. The key active compounds are withanolides — steroidal lactones unique to the Withania genus that have measurable effects on the hypothalamic-pituitary-adrenal (HPA) axis, GABAergic neurotransmission, inflammatory signaling (NF-κB suppression), and gonadotropin release. The clinical relevance of any ashwagandha supplement depends almost entirely on its withanolide concentration — which varies from <0.3% in low-grade root powder to 5%+ in concentrated extracts like KSM-66 and Sensoril.
−27.9%
cortisol reduction (Chandrasekhar 2012) — Chandrasekhar et al. 2012 (Indian Journal of Psychological Medicine): the foundational ashwagandha stress RCT; N=64 adults with self-reported chronic stress; double-blind, placebo-controlled; KSM-66 ashwagandha root extract 300mg BID (600mg/day) vs placebo × 60 days; primary outcomes: serum cortisol (morning), Perceived Stress Scale (PSS), General Health Questionnaire-28, Depression Anxiety Stress Scale (DASS); results: morning serum cortisol: −27.9% vs −7.9% placebo (p<0.0001); Perceived Stress Scale: −44.0% improvement vs −5.5% placebo; sleep quality: significantly improved; food cravings: significantly reduced; no serious adverse events; mechanism: withanolides suppress CRH (corticotropin-releasing hormone) release from the hypothalamus; this reduces ACTH from the pituitary → lower cortisol from the adrenals; the effect is modulatory, not suppressive — ashwagandha normalizes an overactive HPA axis rather than simply blocking cortisol; this is the "adaptogen" pharmacology: bidirectional normalization toward physiological range rather than pharmacological suppression to below-normal levels; subsequent meta-analyses (Pratte 2014, Salve 2019) confirm the cortisol-lowering effect across multiple trials
+17%
testosterone (Wankhede 2015) — Wankhede et al. 2015 (Journal of the International Society of Sports Nutrition): N=57 male resistance-trained adults (18–50 years); double-blind RCT; KSM-66 300mg BID vs placebo × 8 weeks with standardized resistance training protocol; primary outcomes: muscle strength (bench press and leg extension 1RM), muscle recovery (creatine kinase), testosterone, cortisol; results: testosterone: +96.2 ng/dL (+17%) vs placebo +18.0 ng/dL (+3.5%), p=0.004; bench press 1RM: KSM-66 +46.9kg vs placebo +26.4kg; leg extension 1RM: +14.5kg vs +7.6kg; muscle recovery (serum CK as marker of muscle damage): significantly lower in ashwagandha group; body composition: muscle gain +3.3kg (lean mass) vs +1.5kg placebo; mechanism for testosterone: withanolides appear to stimulate LH (luteinizing hormone) production from the pituitary → increased Leydig cell testosterone synthesis; also, cortisol and testosterone are inversely related (cortisol suppresses GnRH → less LH → less testosterone); by reducing cortisol, ashwagandha removes a suppressive signal on the HPG axis; separately, Ambiye 2013 (Evidence-Based Complementary and Alternative Medicine): in infertile men, ashwagandha root 5g/day × 3 months: testosterone +17%, LH +34%, sperm motility +57%
GABA
the anxiolytic mechanism — withanolides (particularly withaferin A and withanolide D) are positive allosteric modulators of the GABA-A receptor — the same receptor targeted by benzodiazepines (Valium, Xanax) and barbiturates; GABA-A modulation: increases chloride ion conductance → hyperpolarization of neurons → reduced neuronal excitability → anxiolytic and sedative effects; Bhattacharya 2000 (Phytotherapy Research): ashwagandha extract produced anxiolytic and anti-stress effects comparable to lorazepam (benzodiazepine) in animal models — without the sedation; the GABA mechanism also explains ashwagandha's sleep benefits: Langade 2019 (Cureus, N=60): KSM-66 300mg BID vs placebo × 10 weeks; sleep onset latency: −72.3% in ashwagandha group; total sleep time: +0.75 hours; sleep quality: significantly improved; the sleep benefit likely synergizes with cortisol reduction (lower evening cortisol → easier sleep onset); additional CNS mechanisms: withanolides cross the blood-brain barrier; Kuboyama 2014: withanolide A promotes axon and dendrite outgrowth in neurons; BDNF (brain-derived neurotrophic factor) upregulation; cognitive studies (Choudhary 2017, Jadaun 2023) show improvements in memory, cognitive processing speed, and reaction time with KSM-66
Thyroid
interaction to know
the thyroid connection — ashwagandha appears to stimulate thyroid hormone production; Sharma 2018 (Journal of Alternative and Complementary Medicine, N=50): subclinical hypothyroidism patients; KSM-66 600mg/day × 8 weeks; T3 increased significantly; T4 increased significantly; TSH decreased; this is potentially beneficial for individuals with subclinical hypothyroidism and is one of the reasons ashwagandha has long been used in Ayurvedic practice for thyroid support; but it is a significant consideration for individuals with hyperthyroidism or Hashimoto's thyroiditis — ashwagandha is typically contraindicated in hyperthyroidism; for Hashimoto's (autoimmune hypothyroid): the effect is controversial; some practitioners use it to support T4→T3 conversion; others avoid it due to potential immune stimulation in an already dysregulated autoimmune context; the NF-κB suppression is anti-inflammatory and could be net beneficial in Hashimoto's, but the thyroid-stimulating effect needs monitoring; practical rule: if you have any thyroid condition, inform your prescribing physician and monitor thyroid function at 3 months after starting ashwagandha; safety note: rare case reports of liver injury with ashwagandha (primarily whole-root powder at high doses or unspecified extracts); standardized extracts like KSM-66 have a substantially better safety profile; avoid if pregnant (uterine stimulant) or with immunosuppressant medications
Want the full evidence writeup?
The Stack Protocol builds four complete goal stacks — Energy, Focus, Sleep, Longevity — with exact doses, timing, budget tiers, and a 30-day rollout plan, graded with the same evidence framework behind this page.
Get the Stack Protocol → $19
Ashwagandha Extract Comparison
| Form | Withanolide % | Source | Clinical Studies | Best For |
|---|
| KSM-66 | ≥5% withanolides | Root extract only (traditional, full-spectrum root) | Most studied — majority of cited RCTs use KSM-66; 24+ clinical trials | Stress, testosterone, athletic performance, sleep — best all-around evidence base |
| Sensoril | ≥10% withanolides + 32% oligosaccharides | Root and leaf extract (higher withanolide by weight) | ~12 clinical trials; effective dose lower (125–250mg vs 300–600mg KSM-66) | Stress, cognitive function, joint health; some prefer lower dose; slightly different withanolide profile |
| Generic root extract (5:1) | Variable (often 1–2.5%) | Root extract, ratio specified without withanolide standardization | Rarely used in RCTs; withanolide content may be substantially lower | Budget option; efficacy less predictable; look for stated withanolide % on label |
| Raw root powder | <0.5% (unstandardized) | Ground whole root | Rarely used in modern trials at typical doses; traditional Ayurvedic use in higher amounts (3–6g) | Traditional use; very high doses (5g/day) have some fertility data; impractical for modern dosing |
Ashwagandha Protocol by Goal
Stress and cortisol reduction: KSM-66 300mg with breakfast + 300mg with dinner (600mg/day total — the dose in Chandrasekhar 2012); take with food; benefits typically emerge at 4–6 weeks; full effect at 8–12 weeks; onset is gradual — this is not a same-day anxiolytic like a benzodiazepine; sustain for at least 8 weeks before assessing response; consider testing morning cortisol before and after 8 weeks to quantify the effect.
Sleep optimization: KSM-66 300mg taken 30–60 minutes before bed; the GABA-A modulation is most useful in the evening; combining with magnesium glycinate (200–400mg) and L-theanine (100–200mg) creates complementary GABAergic stack; do not combine with benzodiazepines or other GABA-active medications without physician oversight.
Athletic performance and testosterone: KSM-66 300mg BID with meals during training block; the Wankhede protocol was 8 weeks with standardized resistance training; cannot replace training stimulus — works synergistically with training by improving recovery (via cortisol modulation) and potentially enhancing the testosterone response to training; retest morning testosterone at 8 weeks if tracking hormonal response.
Cycling: evidence does not definitively require cycling; some practitioners use 8-weeks-on/2-weeks-off cycles as a precaution against receptor desensitization; no strong human data forces this decision; reasonable to take a 2-week break every 2–3 months; monitor for any GI sensitivity or thyroid symptoms.
Ashwagandha KSM-66 →
Cortisol Test →
More evidence-based protocols
As an Amazon Associate, StackProtocol earns from qualifying purchases made through links on this page. This does not affect the price you pay.